This announcement is a separate document:
瑞科生物-B：自願公告 本公司新佐劑重組帶狀疱疹疫苗REC610在菲律賓臨床試驗期中分析取得積極結果
RECBIO-B: VOLUNTARY ANNOUNCEMENT POSITIVE RESULTS IN THE INTERIM ANALYSIS OF THE CLINICAL TRIAL OF THE COMPANY''S NOVEL ADJUVANTED RECOMBINANT SHINGLES VACCINE REC610 IN THE PHILIPPINES
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.